News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

JTHF Creates Postdoctoral Endowed Fellowship at OSU


Posted on: 02/07/2006

JTHF Creates Postdoctoral Endowed Fellowship at OSU

February 6, 2006

The Jeffrey Thomas Hayden Foundation (JTHF) took a major step forward in Making a Difference in the fight against pediatric brain tumors with the creation of an Endowed Fellowship at The Ohio State University College of Medicine. The announcement of this position was made at the very successful JTHF “Play Ball” Dinner and Auction held at the prestigious Manor House in Mason, Ohio on January 14th, 2006. The event helped to raise over $51,000 towards the foundation’s projects.

Under the terms of the agreement reached with The Ohio State University Foundation, JTHF will commit $250,000 over a three-year period to establish the fund which will be used to connect researchers at the university with doctors at various Children’s Hospitals, with the goal of providing doctors an insight to the leading-edge research being done at OSU and to provide feedback to the researchers on promising treatment options. The official name of the fund is “The Jeffrey Thomas Hayden Foundation Postdoctoral Endowed Fellowship Fund in Pediatric Brain Tumor Research at the Ohio State University Arthur G. James Cancer Hospital and the Richard L. Solove Research Institute.” This fund is open for additional contributions above and beyond the initial $250,000. Contact JTHF to learn more about how your gift can help make a difference.

E. Antonio Chiocca MD, PhD, a principal researcher at the Ohio State University Medical Center and Chair of the Department of Neurosurgery, will oversee the Fellowship position as part of his research team. Dr. Chiocca is a world renowned brain tumor expert and has been featured in numerous medical publications. He has authored or co-authored more than 100 articles and book chapters, and holds three patents, with four others pending. He is an outstanding physician-scientist who is nationally recognized as a brain tumor specialist and is a leading investigator in the use of gene therapies for brain tumors and other central nervous system disorders. Recently OSU announced a collaborative effort with Columbus and Cincinnati Children’s Hospitals that extends the research projects and clinical trials that have been developed at OSU for use in adults and children.

Dr. Jennifer Cutter has been named the first recipient of the newly created JTHF Postdoctoral Endowed Fellowship and was introduced by Dr. Chiocca at the Play Ball Dinner and Auction. She has a doctorate in Neuroscience from the University of Cincinnati and is one of the new generation of bright and dedicated researchers at Ohio State. Before joining the team at OSU, Dr. Cutter was a postdoctoral research fellow in the Center for Translational Therapeutics in the Brain Tumor Institute at the Cleveland Clinic. She will be under the direction of Dr. Chiocca and the outstanding experience she brings to OSU will dramatically enhance research in fighting brain tumors.

“The commitment and effort by the Jeffrey Thomas Hayden Foundation will significantly impact the fight against this deadly form of cancer that strikes children and adults in a devastating fashion”, said Dr. Chiocca. “JHTF has recognized that support of scientists at the earliest stages of their career (i.e. during the “postdoctoral fellowship”) is now needed more than ever, so that we can ensure that the brightest and best concentrate their energy in finding the reasons why this cancer happens and discovering a cure.”

JTHF President and Founder, Tim Hayden, stated “The agreement between JTHF and OSU makes good on a commitment made to Jeffrey prior to his passing in September of 2004. This is the first of what we hope are many steps the Foundation will take to help make a difference in the fight against this deadly disease.”

The Jeffrey Thomas Hayden Foundation is a registered 501 (c)(3) non profit organization that was created to Make a Difference in the fight against Pediatric Brain Tumors. For more information visit our web site at www.jthf.org

060206 fellowship announcement


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740